Thomas J. Hoerger

Expertise

Health Economics
Health Promotion Economics
Competitive Bidding
Preventive Medicine

Biography

Thomas Hoerger, PhD, Senior Fellow in health economics and financing, appointed in September 2005, is the director of the RTI-UNC Center of Excellence in Health Promotion Economics. He specializes in health economics, health care reform, and cost-effectiveness analysis. Dr. Hoerger has led numerous research projects for the Centers for Disease Control and Prevention (CDC) and the Centers for Medicare and Medicaid Services (CMS). He has developed models for examining the cost-effectiveness of health promotion interventions and estimated the costs of diabetes, vision loss, and other conditions. He has directed a series of projects to design, implement, and evaluate competitive bidding for Medicare services. The purpose of the CDC-sponsored RTI-UNC Center of Excellence in Health Promotion Economics is to develop, evaluate, and implement health promotion recommendations, programs, and policies; to evaluate their cost-effectiveness; and, consequently, to improve upon efforts to promote health and prevent disease, disability, and injury.

Education

PhD, Economics, Northwestern University; MA, Economics, Northwestern University; BA, Economics, Carleton College.

Selected Publications

Hoerger, T.J. (2009 Jul). Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes. Medical Care, 47 (7 Suppl 1):S21-S27.

Honeycutt, A.A., Segel, J.E., Hoerger, T.J., & Finkelstein, E.A. (2009 Feb). Comparing cost-of-illness estimates from alternative approaches: an application to diabetes. Health Services Research, 44 (1):303-320.

Trogdon, J.G., Finkelstein, E.A., & Hoerger, T.J. (2008 Jan 29). Use of econometric models to estimate expenditure shares. Health Services Research, 43 (4):1442-1452.

Hoerger, T.J., Segel, J.E., Gregg, E.W., & Saaddine, J.B. (Jan 2008). Is glycemic control improving in U.S. adults? Diabetes Care, 31 (1):81-86.

Hoerger, T.J., Hicks, K.A., Sorensen, S.W., Herman, W.H., Ratner, R.E., Ackermann, R.T., Zhang, P., & Engelgau, M.M. (2007 Nov). The cost-effectiveness of screening for prediabetes among overweight and obese U.S. adults. Diabetes Care, 30 (11):2874-2879.

Johnson, F.R., Manjunath, R., Mansfield, C., Clayton, L.J., Hoerger, T.J., & Zhang, P. (2006). High-risk individuals' willingness to pay for diabetes risk-reduction programs. Diabetes Care, 29 (6):1351-1356.

Herman, W.H., Hoerger, T.J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., Hamman, R.F., Ackermann, R.T., Engelgau, M.M., & Ratner, R.E. (2005). The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Annals of Internal Medicine, 142 (5):323-332.

Hoerger, T.J., Harris, R., Hicks, K.A., Donahue, K., Sorensen, S., & Engelgau, M. (2004). Screening for type 2 diabetes mellitus: A cost-effectiveness analysis. Annals of Internal Medicine, 140 (9):689-699.

Honeycutt, A.A., Boyle, J.P., Broglio, K.R., Thompson, T.J., Hoerger, T.J., Geiss, L.S., & Venkat Narayan, K.M. (2003 Aug). A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Management Science, 6 (3):155-164.

Hoerger, T.J., Bethke, A.D., Richter, A., Sorensen, S.W., Engelgau, M., Thompson, T., Narayan, K.M.V., Williamson, D.F., Gregg, E., Zhang, P., Eastman, R.C., Fuller, J., Gibbons, C.B., Haffner, S., Herman, W.H., Howard, B., Ratner, R., & Orchard, T. (2002). Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA, 287 (19):2542-2551.

View all publications by Thomas J. Hoerger…